logo
episode-header-image
Jul 2022
27m 52s

Immunai CTO and Co-Founder Luis Voloch o...

Nvidia
About this episode
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI technology to map the human immune system and speed the development of new imm ... Show More
Up next
Jun 24
Inside Instacart's AI-Powered Smart Shopping Cart | NVIDIA AI Podcast Ep. 302
Instacart has 1.6 billion lifetime grocery orders—and is now using that data flywheel to digitize the physical store itself. In this episode, David McIntosh, Chief Connected Stores Officer at Instacart, explains how the Caper Cart—powered by an NVIDIA Jetson™ board and a sensor f ... Show More
39m 55s
Jun 10
How Mistral Is Building Frontier AI for the Enterprise | NVIDIA AI Podcast Ep. 301
Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ... Show More
21m 33s
May 27
Everyone Can Build a Robot: Open Source Embodied AI With Seeed Studio | NVIDIA AI Podcast Ep. 300
Seeed Studio is a leader in open source robotics, delivering affordable NVIDIA Jetson‑powered arms that put embodied AI into the hands of millions of makers, students, and small businesses. In this episode, Seeed Studio CEO Eric Pan and Head of Robotics Elaine Wu explain how open ... Show More
29m 4s
Recommended Episodes
Jan 2018
Immune 4: Putting the immunotherapy CAR T before the cancer
<p>The immu-knowledge-ists deconstruct the holy grail of oncologists, cancer immunotherapy, and the exciting development of CAR T cells and how they work.</p> <p>Hosts: <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello" target="_blank" rel="noopener">Vincent Racaniello</a ... Show More
1h 23m
Dec 2022
HIBT Lab! Immunai: Noam Solomon
According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop ... Show More
33m 37s
Mar 2023
How to build a virus-proof cell
00:47 An edited genetic code that prevents viral infectionResearchers have engineered bacteria with synthetic genomes to be immune to viral infection. The team streamlined the bacteria’s genetic code, and re-engineered the protein-producing machinery to insert the wrong amino aci ... Show More
31m 38s
May 2021
Robot revolution
A brain-computer interface allows a severely paralysed patient not only to move and use a robotic arm, but also to feel the sensations as the mechanical hand clasps objects . We hear from Jennifer Collinger at Pittsburgh University’s Rehab Neural Engineering Labs. And Nathan Cope ... Show More
36m 17s
Mar 2024
From Single Neurons to AI Systems: The Evolution of Decision Sciences in Medicine with Dr. Eric Horvitz
<p>In this episode of the AI Grand Rounds podcast, Dr. Eric Horvitz describes his career evolution from an interest in neurobiology to significant contributions in AI, particularly in understanding complex systems and applying AI in medicine. He discusses the shift from studying ... Show More
1h 7m
Dec 2020
The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ... Show More
17m 42s
Jul 2023
Immune 70: Immunology of picky eating
tail spinning
1h 7m
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
<p>Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.</p> <p>Grant joins the sho ... Show More
1h 5m